Skip to main content
Article
Indinavir increases midazolam N-glucuronidation in humans: identification of an alternate CYP3A inhibitor using an in vitro to in vivo approach
Drug Metabolism and Disposition (2019)
  • Dan-Dan Tian, Washington State University
  • Cathrine Leonowens, University of North Carolina at Chapel Hill
  • Emily J Cox, Washington State University
  • Vanessa Gonzalez-Perez, Washington State University
  • Kosea S Frederick, Boehringer Ingelheim
  • Yolanda V Scarlett, University of North Carolina at Chapel Hill
  • Michael B Fisher, Boehringer Ingelheim
  • Mary F Paine, Washington State University
Publication Date
April 26, 2019
DOI
10.1124/dmd.119.087007
Citation Information
Dan-Dan Tian, Cathrine Leonowens, Emily J Cox, Vanessa Gonzalez-Perez, et al.. "Indinavir increases midazolam N-glucuronidation in humans: identification of an alternate CYP3A inhibitor using an in vitro to in vivo approach" Drug Metabolism and Disposition (2019)
Available at: http://works.bepress.com/emilyj-cox/8/